oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Auroverin MR

This batch does not meet the specified quality requirements due to a negative test result for the mebeverine hydrochloride release parameter. Potential effects: reduced effectiveness in treating intestinal disorders, possible worsening of disease symptoms.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Auroverin MR
Risk Level
Medium
Manufacturer
Aurovitas Pharma Polska sp. z o.o. z siedzibą w Warszawie
Batch Number
EMBCD2064A
EAN Code
05909991340902
Recall Date
20.03.2024
View official statement

Important Information

What You Should Know

Recommendations

Do not use the product from the specified batches. Check the batch number on the package; if you have the medicine, return it to the pharmacy and consult your doctor or pharmacist about further treatm...

Actions Taken

The Chief Pharmaceutical Inspector withdrew the specified batches of Auroverin MR from the market throughout the country and prohibited their placing on the market, granting the decision immediate enf...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: This batch does not meet the specified quality requirements due to a negative test result for the mebeverine hydrochloride release parameter. Potential effects: reduced effectiveness in treating intestinal disorders, possible worsening of disease symptoms.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: EMBCD2064A

Related

Other Recalled Products